[Increase in NK-activity using superlow doses of the immunomodulator cycloferon]

E V Shevchenko1, B B Finkel'shteĭn, V A Ivanov

  • 1Institute of Cytology RAS, St. Petersburg. shev@svs.ru

Tsitologiia
|September 13, 2001
PubMed